Home LiteratureArticle Details
PMID: 973959 Published · ppublish English Clinical Trial Comparative Study Journal Article Randomized Controlled Trial

beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

British journal of clinical pharmacology ·Vol. 3 ·No. 2 ·1976-04-00 ·Pages 251-7

Aellig WH

Abstract

The beta-adrenoceptor blocking activities of pindolol and propranolol have been investigated in healthy male volunteers. Pindolol was about forty times more potent than propranolol in reducing isoprenaline-induced tachycardia. Pindolol (5 mg) and propranolol (u99 mg) were approximately equiactive in reducing exercise-induced tachycardia, 2 h after oral administration. The duration of action of pindolol is significantly longer than that of propranolol; 24 h after pindolol (kmg), 36+/-5% of the masimum effect were still present, and after propranolol (100 mg) 16+/-4% remained. Despite the long duration of action of pindolol, there was no evidence for cumulation during oral administration of 5 mg t.d.s. for 5 days.

MeSH Terms
Adult Dose-Response Relationship, Drug Heart Rate/drug effects Humans Isoproterenol/antagonists & inhibitors Male Physical Exertion Pindolol/pharmacology Placebos Propranolol/pharmacology Rest
Chemicals
Placebos Propranolol Pindolol Isoproterenol
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Aellig W H
References (9)
9 references, click to expand
  1. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Drugs. 1974;7(1):55-84 PMID: 4151695
  2. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
    Postgrad Med J. 1970 Nov;:Suppl:77-85 PMID: 4395464
  3. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Br J Pharmacol. 1973 Mar;47(3):621P-622P PMID: 4147193
  4. Prolonged action of pindolol.
    Br Med J. 1973 May 12;2(5862):365 PMID: 4634167
  5. Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man.
    Br J Pharmacol. 1969 Jun;36(2):368-72 PMID: 5787671
  6. Pindolol in hypertension: twice-daily versus thrice-daily dosage.
    Med J Aust. 1975 Aug 16;2(7):274-5 PMID: 1160793
  7. The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man.
    Clin Pharmacol Ther. 1975 Feb;17(2):127-33 PMID: 1122674
  8. Plasma propranolol levels in adults with observations in four children.
    Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112-20 PMID: 5410893
  9. Pharmacokinetics of pindolol in man.
    Eur J Clin Pharmacol. 1974;7(1):17-24 PMID: 4853602
Article Info
Journal
British journal of clinical pharmacology
Abbr.
Br J Clin Pharmacol
ISSN
0306-5251
Published
1976-04-00
Pages
251-7
Language
English
Region
England
NLM ID
7503323
PMCID
PMC1428873
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com